๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of flosequinan in patients with heart failure

โœ Scribed by D. P. Nicholls; A. Droogan; C. A. Carson; I. C. Taylor; A. P. Passmore; G. D. Johnston; M. Kendall; D. Dutka; G. K. Morris; L. M. Underwood; I. D. Hind

Publisher
Springer
Year
1996
Tongue
English
Weight
225 KB
Volume
50
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A comparison of the effects of captopril
A comparison of the effects of captopril and flosequinan in patients with severe heart failure
โœ A. J. Cowley; R. D. Wynne; A. Swami; J. Birkhead; A. Skene; J. R. Hampton ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer US ๐ŸŒ English โš– 542 KB

Angiotensin converting enzyme inhibitors have greatly improved the treatment of patients with chronic heart failure but they are not effective in all patients, and their use may be limited by side effects. There is, therefore, a need to investigate new drugs and to compare their efficacy with angiot

The central haemodynamic effects of a si
The central haemodynamic effects of a single intravenous dose of flosequinan in patients with severe heart failure
โœ H. Markus; A. J. Cowley ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 332 KB

The acute central haemodynamic and neuroendocrine effects of intravenous flosequinan were studied in a group of 10 patients with severe heart failure. Flosequinan improved cardiac output by a maximum of 1.59 l.min-1, it reduced pulmonary capillary wedge pressure by 11.9 mm Hg and it also caused a re